Format

Send to

Choose Destination
Ann Dermatol Venereol. 2018 Dec;145 Suppl 7:VIIS11-VIIS16. doi: 10.1016/S0151-9638(18)31284-5.

[What's new in interventional dermatology?]

[Article in French]

Author information

1
Dermatologue libérale, 30, rue des Clercs, 57000 Metz, France, présidente du Groupe de dermatologie esthétique et correctrice (gDEC) de la Société française de dermatologie, past présidente de l'Association de dermatologie esthétique et laser de l'Est (ADELE). Electronic address: raimbault-gerard.catherine@wanadoo.fr.

Abstract

This year, many publications have focused on understanding, avoiding and treating vascular complications when injecting fillers. New protocols for the use of hyaluronidase have shown their effectiveness in preventing skin necrosis or blindness after vascular embolism when injecting hyaluronic acid. Other areas of interventional dermatology have been well documented: myomodulation is an interesting concept that describes the impact of the injection depth of a filler on muscle forces in order to correct the balances between the lowering and elevators during congenital or acquired defcits with aging. Treatment of melasma remains diffcult but the prescription of oral tranexamic acid could be useful. Botulinum toxin is expanding its feld of activity for both aesthetic and medical treatments. Pulsed dye laser remains the reference treatment for port wine stains, but the rate of recurrence by post laser neo-angiogenesis justifes the need of reliable and effective adjuvant treatments.

KEYWORDS:

Acide hyaluronique; Acide tranexamique; Botulinum toxin; Hyaluronic acid; Hyaluronidase; Laser à colorant pulsé; Myomodulation; Toxine botulinique; Tranexamic acid; pulse dye laser

Supplemental Content

Full text links

Icon for Masson (France)
Loading ...
Support Center